Teva Pharmaceutical Q3 2024 Earnings Preview

  • Teva Pharmaceutical (NYSE:TEVA) is scheduled to announce Q3 earnings results on Wednesday, November 6th, before market open.
  • The consensus EPS Estimate is $0.66 (+10.0% Y/Y) and the consensus Revenue Estimate is $4.13B (+5.9% Y/Y).
  • Over the last 2 years, TEVA

Leave a Reply

Your email address will not be published. Required fields are marked *